DS Healthcare Group to Present at 3rd Annual Marcum MicroCap Conference on May
Pompano Beach, Fla., May 13, 2014 (GLOBE NEWSWIRE) -- DS Healthcare Group,
Inc. (NASDAQ: DSKX), a leading developer of personal care products and
specialty pharmaceuticals announced that the Company will present at the Third
Annual Marcum MicroCap Conference in New York City on May 29, 2014 at the
Grand Hyatt New York. Since 2012, the Marcum conference has introduced
investors to promising undiscovered companies with a market capitalization of
under $500 million. As part of the conference, DS Healthcare will participate
in one-on-one meetings with investors and other companies.
"This is an excellent opportunity from which to get exposure and increase
investor awareness," said DS Healthcare CEO Daniel Khesin. "We believe that
with our cutting-edge topical technologies, products, vast distribution
andconsistentgrowing revenues, we are a very compelling investment
opportunity that has not yet been discovered."
Presentation time and details:
• Location: Grand Hyatt New York (109 E 42nd Street, New York, NY 10017)
• Date: May 29, 2014
• Time: 10:00 - 10:30 AM EST
• Room: Broadway
To schedule a one-on-one meeting with management, please contact Abner Silva
by email at: Abner@DSHealthgroup.com
About the Marcum MicroCap Conference
The Marcum MicroCap Conference is dedicated to introducing investors to the
very best, undiscovered companies under $500 million in market capitalization.
Launched in 2012, the annual Marcum MicroCap Conference features presentations
by CEOs and CFOs from promising high-growth companies, the top picks by some
of the most astute analysts following small caps, and thoughtful commentary on
successful investment strategies and sectors. This invitation-only event
attracts top fund managers and qualified high net worth investors who focus on
small cap equities. One-on-one meetings are available for company management
teams and qualified investors.
About DS Healthcare Group
DS Healthcare Group Inc. leads in the development of biotechnology for topical
therapies. It markets through online and specialty retailers, distributors,
cosmetics wholesalers, and salons. Its research has led to a highly innovative
portfolio of personal care products and additional innovations in
pharmaceutical projects. For more information on DS Health Group's flagship
brand, visit www.dslaboratories.com
Except for statements of historical fact, the matters discussed in this press
release are forward-looking and made pursuant to the Safe Harbor provisions of
the Private Securities Litigation Reform Act of 1995. "Forward-looking
statements" describe future expectations, plans, results, or strategies, and
are generally preceded by words such as "future," "plan" or "planned,"
"expects," or "projected." These forward-looking statements reflect numerous
assumptions and involve a variety of risks and uncertainties, many of which
are beyond the company's control that may cause actual results to differ
materially from stated expectations. These risk factors include, among others,
limited operating history, difficulty in developing and marketing products,
intense competition, and additional risks factors as discussed in reports
filed by the company with the Securities and Exchange Commission, which are
available at http://www.sec.gov.
CONTACT: Laurel Moody
DS Healthcare Group,Inc.
Press spacebar to pause and continue. Press esc to stop.